Answer: Genvoya (Elvitegravir/cobicistat, tenofovir alafenamide, emtricitabine); 1 tablet (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir alafenamide 10 mg) orally once daily with food; indefinitely duration
Rational:
Based on the U.S. Department of Health and Human Services’ guideline for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV, the recommended initial regimens are DTG/ABC/3TC, DTG+tenofovir/FTC, EVG/c/tenofovir/FTC, RAL+tenofovir/FTC. There are several patients’ specific characteristics we need to consider. Firstly, the patient’s HLA-B*5701 test is positive, we need to avoid using ABC containing regimens. Secondly, the patient’s CD4 count is 575 cells/mm3, which is greater than 200
Rational:
Based on the U.S. Department of Health and Human Services’ guideline for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV, the recommended initial regimens are DTG/ABC/3TC, DTG+tenofovir/FTC, EVG/c/tenofovir/FTC, RAL+tenofovir/FTC. There are several patients’ specific characteristics we need to consider. Firstly, the patient’s HLA-B*5701 test is positive, we need to avoid using ABC containing regimens. Secondly, the patient’s CD4 count is 575 cells/mm3, which is greater than 200